foxo4-dri peptide senolytic study The disordered p53 transactivation domain is the target of FOXO4 and the compound ⚔️ FOXO4-DRI 10 mg (Proxofim)
FOXO4 DRI 10 mg (Proxofim) Cellular Senolytic Peptide TirzMaxx Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging
Pay in 4 interest-free payments of $6.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12


